As the first election numbers came rolling in, CNN contributor Ana Navarro pointed out that the influx of Latino voters angered by GOP presidential nominee Donald Trump’s hateful rhetoric could swing the election to Hillary Clinton, calling it “sweet sweet justice.”
Noting a GOP post-mortem after the 2012 election showed Romney only received 27 percent of Hispanic votes, the GOP consultant said it was a warning sign.
“Now we’re worst than post-mortem and I can assure you that Donald Trump is going to get historic low numbers amongst Latinos,” she explained. “Probably going to be in the teens. If he breaks 20, it’s a good night for him with Latinos.”
Navarro then hit her stride.
“And it would be sweet, sweet justice if, after everything he has said, after every attack he has made against Latinos, after he has thrown out Latino anchors from press events, after he hasn’t done any outreach, after he has questioned and judged our citizenship, after he has called Mexican ‘rapists,’ it would be sweet, sweet justice if it was the Latino vote that defeated Donald Trump.”
Watch the video below via CNN:
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.